Table of Contents 1 Gabapentin Market Overview 1.1 Product Overview and Scope of Gabapentin 1.2 Gabapentin Segment by Type 1.2.1 Global Gabapentin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Capsule 1.2.3 Tablet 1.3 Gabapentin Segment by Application 1.3.1 Gabapentin Sales Comparison by Application: 2020 VS 2026 1.3.2 Epilepsy 1.3.3 Neuropathic Pain 1.3.4 Restless Legs Syndrome 1.3.5 Others 1.4 Global Gabapentin Market Size Estimates and Forecasts 1.4.1 Global Gabapentin Revenue 2015-2026 1.4.2 Global Gabapentin Sales 2015-2026 1.4.3 Gabapentin Market Size by Region: 2020 Versus 2026 2 Global Gabapentin Market Competition by Manufacturers 2.1 Global Gabapentin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Gabapentin Revenue Share by Manufacturers (2015-2020) 2.3 Global Gabapentin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Gabapentin Manufacturing Sites, Area Served, Product Type 2.5 Gabapentin Market Competitive Situation and Trends 2.5.1 Gabapentin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Gabapentin Players (Opinion Leaders) 3 Gabapentin Retrospective Market Scenario by Region 3.1 Global Gabapentin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Gabapentin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Gabapentin Market Facts & Figures by Country 3.3.1 North America Gabapentin Sales by Country 3.3.2 North America Gabapentin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Gabapentin Market Facts & Figures by Country 3.4.1 Europe Gabapentin Sales by Country 3.4.2 Europe Gabapentin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Gabapentin Market Facts & Figures by Region 3.5.1 Asia Pacific Gabapentin Sales by Region 3.5.2 Asia Pacific Gabapentin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Gabapentin Market Facts & Figures by Country 3.6.1 Latin America Gabapentin Sales by Country 3.6.2 Latin America Gabapentin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Gabapentin Market Facts & Figures by Country 3.7.1 Middle East and Africa Gabapentin Sales by Country 3.7.2 Middle East and Africa Gabapentin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Gabapentin Historic Market Analysis by Type 4.1 Global Gabapentin Sales Market Share by Type (2015-2020) 4.2 Global Gabapentin Revenue Market Share by Type (2015-2020) 4.3 Global Gabapentin Price Market Share by Type (2015-2020) 4.4 Global Gabapentin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Gabapentin Historic Market Analysis by Application 5.1 Global Gabapentin Sales Market Share by Application (2015-2020) 5.2 Global Gabapentin Revenue Market Share by Application (2015-2020) 5.3 Global Gabapentin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Gabapentin Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 Assertio Therapeutics 6.2.1 Assertio Therapeutics Gabapentin Production Sites and Area Served 6.2.2 Assertio Therapeutics Description, Business Overview and Total Revenue 6.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Assertio Therapeutics Products Offered 6.2.5 Assertio Therapeutics Recent Development 6.3 TEVA 6.3.1 TEVA Gabapentin Production Sites and Area Served 6.3.2 TEVA Description, Business Overview and Total Revenue 6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 TEVA Products Offered 6.3.5 TEVA Recent Development 6.4 Mylan 6.4.1 Mylan Gabapentin Production Sites and Area Served 6.4.2 Mylan Description, Business Overview and Total Revenue 6.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Mylan Products Offered 6.4.5 Mylan Recent Development 6.5 Arbor Pharma 6.5.1 Arbor Pharma Gabapentin Production Sites and Area Served 6.5.2 Arbor Pharma Description, Business Overview and Total Revenue 6.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Arbor Pharma Products Offered 6.5.5 Arbor Pharma Recent Development 6.6 Novartis 6.6.1 Novartis Gabapentin Production Sites and Area Served 6.6.2 Novartis Description, Business Overview and Total Revenue 6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Novartis Products Offered 6.6.5 Novartis Recent Development 6.7 Apotex 6.6.1 Apotex Gabapentin Production Sites and Area Served 6.6.2 Apotex Description, Business Overview and Total Revenue 6.6.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Apotex Products Offered 6.7.5 Apotex Recent Development 6.8 Sun Pharmaceutical 6.8.1 Sun Pharmaceutical Gabapentin Production Sites and Area Served 6.8.2 Sun Pharmaceutical Description, Business Overview and Total Revenue 6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Sun Pharmaceutical Products Offered 6.8.5 Sun Pharmaceutical Recent Development 6.9 Aurobindo Pharma 6.9.1 Aurobindo Pharma Gabapentin Production Sites and Area Served 6.9.2 Aurobindo Pharma Description, Business Overview and Total Revenue 6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Aurobindo Pharma Products Offered 6.9.5 Aurobindo Pharma Recent Development 6.10 Intas 6.10.1 Intas Gabapentin Production Sites and Area Served 6.10.2 Intas Description, Business Overview and Total Revenue 6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Intas Products Offered 6.10.5 Intas Recent Development 6.11 Amneal 6.11.1 Amneal Gabapentin Production Sites and Area Served 6.11.2 Amneal Gabapentin Description, Business Overview and Total Revenue 6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Amneal Products Offered 6.11.5 Amneal Recent Development 6.12 Marksans Pharma 6.12.1 Marksans Pharma Gabapentin Production Sites and Area Served 6.12.2 Marksans Pharma Gabapentin Description, Business Overview and Total Revenue 6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Marksans Pharma Products Offered 6.12.5 Marksans Pharma Recent Development 6.13 Glenmark 6.13.1 Glenmark Gabapentin Production Sites and Area Served 6.13.2 Glenmark Gabapentin Description, Business Overview and Total Revenue 6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Glenmark Products Offered 6.13.5 Glenmark Recent Development 6.14 Alkem 6.14.1 Alkem Gabapentin Production Sites and Area Served 6.14.2 Alkem Gabapentin Description, Business Overview and Total Revenue 6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Alkem Products Offered 6.14.5 Alkem Recent Development 6.15 Jiangsu Enhua 6.15.1 Jiangsu Enhua Gabapentin Production Sites and Area Served 6.15.2 Jiangsu Enhua Gabapentin Description, Business Overview and Total Revenue 6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Jiangsu Enhua Products Offered 6.15.5 Jiangsu Enhua Recent Development 6.16 Jiangsu Hengrui 6.16.1 Jiangsu Hengrui Gabapentin Production Sites and Area Served 6.16.2 Jiangsu Hengrui Gabapentin Description, Business Overview and Total Revenue 6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Jiangsu Hengrui Products Offered 6.16.5 Jiangsu Hengrui Recent Development 6.17 Sailike 6.17.1 Sailike Gabapentin Production Sites and Area Served 6.17.2 Sailike Gabapentin Description, Business Overview and Total Revenue 6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Sailike Products Offered 6.17.5 Sailike Recent Development 7 Gabapentin Manufacturing Cost Analysis 7.1 Gabapentin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Gabapentin 7.4 Gabapentin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Gabapentin Distributors List 8.3 Gabapentin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Gabapentin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Gabapentin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Gabapentin by Type (2021-2026) 10.2 Gabapentin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Gabapentin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Gabapentin by Application (2021-2026) 10.3 Gabapentin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Gabapentin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Gabapentin by Region (2021-2026) 10.4 North America Gabapentin Estimates and Projections (2021-2026) 10.5 Europe Gabapentin Estimates and Projections (2021-2026) 10.6 Asia Pacific Gabapentin Estimates and Projections (2021-2026) 10.7 Latin America Gabapentin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Gabapentin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Gabapentin Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Gabapentin Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Gabapentin Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Gabapentin Manufacturers Covered in This Study Table 5. Global Gabapentin Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Gabapentin Sales Share by Manufacturers (2015-2020) Table 7. Global Gabapentin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Gabapentin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Gabapentin Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Gabapentin Sales Sites and Area Served Table 11. Manufacturers Gabapentin Product Types Table 12. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Gabapentin Players Table 16. Global Gabapentin Sales (K MT) by Region (2015-2020) Table 17. Global Gabapentin Sales Market Share by Region (2015-2020) Table 18. Global Gabapentin Revenue (Million US$) by Region (2015-2020) Table 19. Global Gabapentin Revenue Market Share by Region (2015-2020) Table 20. North America Gabapentin Sales by Country (2015-2020) (K MT) Table 21. North America Gabapentin Sales Market Share by Country (2015-2020) Table 22. North America Gabapentin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Gabapentin Revenue Market Share by Country (2015-2020) Table 24. Europe Gabapentin Sales by Country (2015-2020) (K MT) Table 25. Europe Gabapentin Sales Market Share by Country (2015-2020) Table 26. Europe Gabapentin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Gabapentin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Gabapentin Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Gabapentin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Gabapentin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Gabapentin Revenue Market Share by Region (2015-2020) Table 32. Latin America Gabapentin Sales by Country (2015-2020) (K MT) Table 33. Latin America Gabapentin Sales Market Share by Country (2015-2020) Table 34. Latin America Gabapentin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Gabapentin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Gabapentin Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Gabapentin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Gabapentin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Gabapentin Revenue Market Share by Country (2015-2020) Table 40. Global Gabapentin Sales (K MT) by Type (2015-2020) Table 41. Global Gabapentin Sales Share by Type (2015-2020) Table 42. Global Gabapentin Revenue (Million US$) by Type (2015-2020) Table 43. Global Gabapentin Revenue Share by Type (2015-2020) Table 44. Global Gabapentin Price (USD/MT) by Type (2015-2020) Table 45. Global Gabapentin Sales (K MT) by Application (2015-2020) Table 46. Global Gabapentin Sales Market Share by Application (2015-2020) Table 47. Global Gabapentin Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Gabapentin Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Assertio Therapeutics Gabapentin Corporation Information Table 54. Assertio Therapeutics Corporation Information Table 55. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Assertio Therapeutics Main Product Table 57. Assertio Therapeutics Recent Development Table 58. TEVA Gabapentin Corporation Information Table 59. TEVA Corporation Information Table 60. TEVA Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. TEVA Main Product Table 62. TEVA Recent Development Table 63. Mylan Gabapentin Corporation Information Table 64. Mylan Corporation Information Table 65. Mylan Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Mylan Main Product Table 67. Mylan Recent Development Table 68. Arbor Pharma Gabapentin Corporation Information Table 69. Arbor Pharma Corporation Information Table 70. Arbor Pharma Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Arbor Pharma Main Product Table 72. Arbor Pharma Recent Development Table 73. Novartis Gabapentin Corporation Information Table 74. Novartis Corporation Information Table 75. Novartis Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Novartis Main Product Table 77. Novartis Recent Development Table 78. Apotex Gabapentin Corporation Information Table 79. Apotex Corporation Information Table 80. Apotex Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Apotex Main Product Table 82. Apotex Recent Development Table 83. Sun Pharmaceutical Gabapentin Corporation Information Table 84. Sun Pharmaceutical Corporation Information Table 85. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Sun Pharmaceutical Main Product Table 87. Sun Pharmaceutical Recent Development Table 88. Aurobindo Pharma Gabapentin Corporation Information Table 89. Aurobindo Pharma Corporation Information Table 90. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Aurobindo Pharma Main Product Table 92. Aurobindo Pharma Recent Development Table 93. Intas Gabapentin Corporation Information Table 94. Intas Corporation Information Table 95. Intas Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Intas Main Product Table 97. Intas Recent Development Table 98. Amneal Gabapentin Corporation Information Table 99. Amneal Corporation Information Table 100. Amneal Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Amneal Main Product Table 102. Amneal Recent Development Table 103. Marksans Pharma Gabapentin Corporation Information Table 104. Marksans Pharma Corporation Information Table 105. Marksans Pharma Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Marksans Pharma Main Product Table 107. Marksans Pharma Recent Development Table 108. Glenmark Gabapentin Corporation Information Table 109. Glenmark Corporation Information Table 110. Glenmark Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Glenmark Main Product Table 112. Glenmark Recent Development Table 113. Alkem Gabapentin Corporation Information Table 114. Alkem Corporation Information Table 115. Alkem Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. Alkem Main Product Table 117. Alkem Recent Development Table 118. Jiangsu Enhua Gabapentin Corporation Information Table 119. Jiangsu Enhua Corporation Information Table 120. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 121. Jiangsu Enhua Main Product Table 122. Jiangsu Enhua Recent Development Table 123. Jiangsu Hengrui Gabapentin Corporation Information Table 124. Jiangsu Hengrui Corporation Information Table 125. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 126. Jiangsu Hengrui Main Product Table 127. Jiangsu Hengrui Recent Development Table 128. Sailike Gabapentin Corporation Information Table 129. Sailike Corporation Information Table 130. Sailike Gabapentin Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 131. Sailike Main Product Table 132. Sailike Recent Development Table 133. Sales Base and Market Concentration Rate of Raw Material Table 134. Key Suppliers of Raw Materials Table 135. Gabapentin Distributors List Table 136. Gabapentin Customers List Table 137. Market Key Trends Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 139. Key Challenges Table 140. Global Gabapentin Sales (K MT) Forecast by Type (2021-2026) Table 141. Global Gabapentin Sales Market Share Forecast by Type (2021-2026) Table 142. Global Gabapentin Revenue (Million US$) Forecast by Type (2021-2026) Table 143. Global Gabapentin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 144. Global Gabapentin Sales (K MT) Forecast by Application (2021-2026) Table 145. Global Gabapentin Revenue (Million US$) Forecast by Application (2021-2026) Table 146. Global Gabapentin Sales (K MT) Forecast by Region (2021-2026) Table 147. Global Gabapentin Sales Market Share Forecast by Region (2021-2026) Table 148. Global Gabapentin Revenue Forecast by Region (2021-2026) (US$ Million) Table 149. Global Gabapentin Revenue Market Share Forecast by Region (2021-2026) Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Gabapentin Figure 2. Global Gabapentin Sales Market Share by Type: 2020 VS 2026 Figure 3. Capsule Product Picture Figure 4. Tablet Product Picture Figure 5. Global Gabapentin Consumption Market Share by Application: 2020 VS 2026 Figure 6. Epilepsy Figure 7. Neuropathic Pain Figure 8. Restless Legs Syndrome Figure 9. Others Figure 10. Global Gabapentin Market Size 2015-2026 (US$ Million) Figure 11. Global Gabapentin Sales Capacity (K MT) (2015-2026) Figure 12. Global Gabapentin Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Gabapentin Sales Share by Manufacturers in 2020 Figure 14. Global Gabapentin Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Revenue in 2019 Figure 16. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Gabapentin Sales Market Share by Region (2015-2020) Figure 18. Global Gabapentin Sales Market Share by Region in 2019 Figure 19. Global Gabapentin Revenue Market Share by Region (2015-2020) Figure 20. Global Gabapentin Revenue Market Share by Region in 2019 Figure 21. North America Gabapentin Sales Market Share by Country in 2019 Figure 22. North America Gabapentin Revenue Market Share by Country in 2019 Figure 23. U.S. Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 24. U.S. Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 26. Canada Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Gabapentin Sales Market Share by Country in 2019 Figure 28. Europe Gabapentin Revenue Market Share by Country in 2019 Figure 29. Germany Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 30. Germany Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 32. France Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 34. U.K. Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 36. Italy Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 38. Russia Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Gabapentin Sales Market Share by Region in 2019 Figure 40. Asia Pacific Gabapentin Revenue Market Share by Region in 2019 Figure 41. China Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 42. China Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 44. Japan Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 46. South Korea Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 48. India Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 50. Australia Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 52. Taiwan Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 54. Indonesia Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 56. Thailand Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 58. Malaysia Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 60. Philippines Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 62. Vietnam Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Gabapentin Sales Market Share by Country in 2019 Figure 64. Latin America Gabapentin Revenue Market Share by Country in 2019 Figure 65. Mexico Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 66. Mexico Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 68. Brazil Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 70. Argentina Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Gabapentin Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Gabapentin Revenue Market Share by Country in 2019 Figure 73. Turkey Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 74. Turkey Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 76. Saudi Arabia Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Gabapentin Sales Growth Rate (2015-2020) (K MT) Figure 78. U.A.E Gabapentin Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Gabapentin by Type (2015-2020) Figure 80. Sales Market Share of Gabapentin by Type in 2019 Figure 81. Revenue Share of Gabapentin by Type (2015-2020) Figure 82. Revenue Market Share of Gabapentin by Type in 2019 Figure 83. Global Gabapentin Sales Growth by Type (2015-2020) (K MT) Figure 84. Global Gabapentin Sales Market Share by Application (2015-2020) Figure 85. Global Gabapentin Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Gabapentin by Application (2015-2020) Figure 87. Global Revenue Share of Gabapentin by Application in 2020 Figure 88. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Assertio Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. TEVA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Arbor Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Apotex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Intas Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Amneal Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Marksans Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Alkem Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Jiangsu Enhua Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Jiangsu Hengrui Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Sailike Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Price Trend of Key Raw Materials Figure 106. Manufacturing Cost Structure of Gabapentin Figure 107. Manufacturing Process Analysis of Gabapentin Figure 108. Gabapentin Industrial Chain Analysis Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Porter's Five Forces Analysis Figure 112. North America Gabapentin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. North America Gabapentin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Europe Gabapentin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Europe Gabapentin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Latin America Gabapentin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Latin America Gabapentin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Middle East and Africa Gabapentin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. Middle East and Africa Gabapentin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Asia Pacific Gabapentin Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 121. Asia Pacific Gabapentin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Bottom-up and Top-down Approaches for This Report Figure 123. Data Triangulation Figure 124. Key Executives Interviewed

Pfizer Assertio Therapeutics TEVA Mylan Arbor Pharma Novartis Apotex Sun Pharmaceutical Aurobindo Pharma Intas Amneal Marksans Pharma Glenmark Alkem Jiangsu Enhua Jiangsu Hengrui Sailike